BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

503 related articles for article (PubMed ID: 25521685)

  • 1. The balance between protective and pathogenic immune responses in the TB-infected lung.
    Orme IM; Robinson RT; Cooper AM
    Nat Immunol; 2015 Jan; 16(1):57-63. PubMed ID: 25521685
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human IL-32 expression protects mice against a hypervirulent strain of Mycobacterium tuberculosis.
    Bai X; Shang S; Henao-Tamayo M; Basaraba RJ; Ovrutsky AR; Matsuda JL; Takeda K; Chan MM; Dakhama A; Kinney WH; Trostel J; Bai A; Honda JR; Achcar R; Hartney J; Joosten LA; Kim SH; Orme I; Dinarello CA; Ordway DJ; Chan ED
    Proc Natl Acad Sci U S A; 2015 Apr; 112(16):5111-6. PubMed ID: 25820174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early T-cell responses in tuberculosis immunity.
    Winslow GM; Cooper A; Reiley W; Chatterjee M; Woodland DL
    Immunol Rev; 2008 Oct; 225():284-99. PubMed ID: 18837789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Host defense mechanisms against Mycobacterium tuberculosis.
    Chai Q; Lu Z; Liu CH
    Cell Mol Life Sci; 2020 May; 77(10):1859-1878. PubMed ID: 31720742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The onset of adaptive immunity in the mouse model of tuberculosis and the factors that compromise its expression.
    Robinson RT; Orme IM; Cooper AM
    Immunol Rev; 2015 Mar; 264(1):46-59. PubMed ID: 25703551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tuberculosis vaccine promises sterilizing immunity.
    McShane H; Williams A
    Nat Med; 2011 Oct; 17(10):1185-6. PubMed ID: 21988991
    [No Abstract]   [Full Text] [Related]  

  • 7. Intestinal microbiota disruption limits the isoniazid mediated clearance of Mycobacterium tuberculosis in mice.
    Negi S; Pahari S; Bashir H; Agrewala JN
    Eur J Immunol; 2020 Dec; 50(12):1976-1987. PubMed ID: 32673409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Protective immunity against Mycobacterium tuberculosis].
    Kawamura I
    Kekkaku; 2006 Nov; 81(11):687-91. PubMed ID: 17154048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Innate Immune Defenses in Human Tuberculosis: An Overview of the Interactions between Mycobacterium tuberculosis and Innate Immune Cells.
    Sia JK; Georgieva M; Rengarajan J
    J Immunol Res; 2015; 2015():747543. PubMed ID: 26258152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Immune response to Mycobacterium tuberculosis].
    Nowag A; Hartmann P
    Internist (Berl); 2016 Feb; 57(2):107-16. PubMed ID: 26838368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Innate and Adaptive Cellular Immune Responses to Mycobacterium tuberculosis Infection.
    Mayer-Barber KD; Barber DL
    Cold Spring Harb Perspect Med; 2015 Jul; 5(12):. PubMed ID: 26187873
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of Mycobacterium tuberculosis-specific interleukin-17A-producing CD4+ T cells in active disease.
    Perreau M; Rozot V; Welles HC; Belluti-Enders F; Vigano S; Maillard M; Dorta G; Mazza-Stalder J; Bart PA; Roger T; Calandra T; Nicod L; Harari A
    Eur J Immunol; 2013 Apr; 43(4):939-48. PubMed ID: 23436562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Immunological protection against Mycobacterium tuberculosis infection].
    Yoshikai Y
    Tanpakushitsu Kakusan Koso; 2009 Jun; 54(8 Suppl):1014-9. PubMed ID: 21089533
    [No Abstract]   [Full Text] [Related]  

  • 14. A recombinant Mycobacterium smegmatis induces potent bactericidal immunity against Mycobacterium tuberculosis.
    Sweeney KA; Dao DN; Goldberg MF; Hsu T; Venkataswamy MM; Henao-Tamayo M; Ordway D; Sellers RS; Jain P; Chen B; Chen M; Kim J; Lukose R; Chan J; Orme IM; Porcelli SA; Jacobs WR
    Nat Med; 2011 Sep; 17(10):1261-8. PubMed ID: 21892180
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Host innate and Th1 responses and the bacterial factors that control Mycobacterium tuberculosis infection.
    Salgame P
    Curr Opin Immunol; 2005 Aug; 17(4):374-80. PubMed ID: 15963709
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New Players in Immunity to Tuberculosis: The Host Microbiome, Lung Epithelium, and Innate Immune Cells.
    Gupta N; Kumar R; Agrawal B
    Front Immunol; 2018; 9():709. PubMed ID: 29692778
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Ag85B protein of Mycobacterium tuberculosis may turn a protective immune response induced by Ag85B-DNA vaccine into a potent but non-protective Th1 immune response in mice.
    Palma C; Iona E; Giannoni F; Pardini M; Brunori L; Orefici G; Fattorini L; Cassone A
    Cell Microbiol; 2007 Jun; 9(6):1455-65. PubMed ID: 17250590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of diabetes mellitus on immunity to human tuberculosis.
    Kumar Nathella P; Babu S
    Immunology; 2017 Sep; 152(1):13-24. PubMed ID: 28543817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mycobacterium tuberculosis growth control by lung macrophages and CD8 cells from patient contacts.
    Carranza C; Juárez E; Torres M; Ellner JJ; Sada E; Schwander SK
    Am J Respir Crit Care Med; 2006 Jan; 173(2):238-45. PubMed ID: 16210664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A multistage-polyepitope vaccine protects against Mycobacterium tuberculosis infection in HLA-DR3 transgenic mice.
    Geluk A; van den Eeden SJ; van Meijgaarden KE; Dijkman K; Franken KL; Ottenhoff TH
    Vaccine; 2012 Dec; 30(52):7513-21. PubMed ID: 23103299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.